000 | 02009 a2200577 4500 | ||
---|---|---|---|
005 | 20250518015840.0 | ||
264 | 0 | _c20190417 | |
008 | 201904s 0 0 eng d | ||
022 | _a1095-6859 | ||
024 | 7 |
_a10.1016/j.ygyno.2018.12.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFabbro, Michel | |
245 | 0 | 0 |
_aEfficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial. _h[electronic resource] |
260 |
_bGynecologic oncology _c03 2019 |
||
300 |
_a560-567 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndazoles _xadverse effects |
650 | 0 | 4 | _aMaintenance Chemotherapy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 | _aPatient Reported Outcome Measures |
650 | 0 | 4 |
_aPiperidines _xadverse effects |
650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerase Inhibitors _xadverse effects |
700 | 1 | _aMoore, Kathleen N | |
700 | 1 | _aDørum, Anne | |
700 | 1 | _aTinker, Anna V | |
700 | 1 | _aMahner, Sven | |
700 | 1 | _aBover, Isabel | |
700 | 1 | _aBanerjee, Susana | |
700 | 1 | _aTognon, Germana | |
700 | 1 | _aGoffin, Frederic | |
700 | 1 | _aShapira-Frommer, Ronnie | |
700 | 1 | _aWenham, Robert M | |
700 | 1 | _aHellman, Kristina | |
700 | 1 | _aProvencher, Diane | |
700 | 1 | _aHarter, Philipp | |
700 | 1 | _aVázquez, Isabel Palacio | |
700 | 1 | _aFollana, Philippe | |
700 | 1 | _aPineda, Mario J | |
700 | 1 | _aMirza, Mansoor R | |
700 | 1 | _aHazard, Sebastien J | |
700 | 1 | _aMatulonis, Ursula A | |
773 | 0 |
_tGynecologic oncology _gvol. 152 _gno. 3 _gp. 560-567 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2018.12.009 _zAvailable from publisher's website |
999 |
_c29249879 _d29249879 |